drugset / Trial / NCT01035853

Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization

NCT01035853

Phase 2 Completed 10 enrolled University of Jena
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the nasal inhalation of Colistin is effective to decrease the Pseudomonas aeruginosa bacterial count in the nasal lavage fluid.

Timeline

Start
2009-12
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 1 ml Intranasal